Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea
· Delayed Price · Currency is KRW 13,050
+10 (0.08%)
At close: Sep 10, 2025
KRX:007570 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 9, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 233,921 | 205,533 | 281,258 | 349,981 | 510,655 | 1,197,901 | Upgrade
|
| Market Cap Growth | -14.71% | -26.92% | -19.64% | -31.46% | -57.37% | 191.80% | Upgrade
|
| Enterprise Value | 344,573 | 341,070 | 394,941 | 436,337 | 605,360 | 1,322,774 | Upgrade
|
| Last Close Price | 13050.00 | 11410.00 | 15441.15 | 18905.81 | 27200.55 | 63349.14 | Upgrade
|
| PE Ratio | 14.72 | 21.04 | - | 18.49 | 36.39 | 110.11 | Upgrade
|
| Forward PE | - | 49.90 | 49.90 | 49.90 | 49.90 | 49.90 | Upgrade
|
| PS Ratio | 0.85 | 0.76 | 1.06 | 1.41 | 2.11 | 3.49 | Upgrade
|
| PB Ratio | 0.94 | 0.85 | 1.22 | 1.47 | 2.25 | 4.89 | Upgrade
|
| P/TBV Ratio | 0.97 | 0.88 | 1.26 | 1.51 | 2.32 | 5.92 | Upgrade
|
| P/FCF Ratio | - | - | 32.19 | 180.62 | 13.07 | 25.32 | Upgrade
|
| P/OCF Ratio | 17.42 | 36.60 | 19.24 | 59.49 | 9.93 | 20.84 | Upgrade
|
| EV/Sales Ratio | 1.25 | 1.27 | 1.48 | 1.76 | 2.50 | 3.85 | Upgrade
|
| EV/EBITDA Ratio | 19.60 | 16.38 | 13.93 | 16.77 | 22.92 | 28.29 | Upgrade
|
| EV/EBIT Ratio | 38.35 | 31.01 | 24.11 | 30.62 | 39.86 | 38.79 | Upgrade
|
| EV/FCF Ratio | -47.13 | - | 45.21 | 225.19 | 15.50 | 27.96 | Upgrade
|
| Debt / Equity Ratio | 0.48 | 0.45 | 0.32 | 0.31 | 0.43 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 7.26 | 5.17 | 2.56 | 2.85 | 3.73 | 2.20 | Upgrade
|
| Debt / FCF Ratio | - | - | 8.32 | 38.24 | 2.52 | 2.18 | Upgrade
|
| Asset Turnover | 0.56 | 0.65 | 0.67 | 0.60 | 0.56 | 0.78 | Upgrade
|
| Inventory Turnover | 2.12 | 2.79 | 2.96 | 3.46 | 3.40 | 3.17 | Upgrade
|
| Quick Ratio | 0.43 | 0.39 | 0.47 | 0.46 | 0.59 | 0.60 | Upgrade
|
| Current Ratio | 0.92 | 0.80 | 0.89 | 0.82 | 0.81 | 0.92 | Upgrade
|
| Return on Equity (ROE) | 6.37% | 4.45% | -0.87% | 8.53% | 6.25% | 9.21% | Upgrade
|
| Return on Assets (ROA) | 1.00% | 1.67% | 2.57% | 2.17% | 2.21% | 4.86% | Upgrade
|
| Return on Capital (ROIC) | 1.29% | 2.11% | 3.33% | 2.79% | 2.82% | 6.10% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.70% | 4.00% | 6.50% | 5.50% | 6.00% | 13.00% | Upgrade
|
| Earnings Yield | 6.80% | 4.99% | -0.86% | 5.54% | 2.75% | 0.91% | Upgrade
|
| FCF Yield | -3.13% | -15.85% | 3.11% | 0.55% | 7.65% | 3.95% | Upgrade
|
| Dividend Yield | 1.15% | 1.31% | 0.97% | - | - | - | Upgrade
|
| Payout Ratio | 17.56% | 29.00% | - | 20.34% | 16.74% | 45.05% | Upgrade
|
| Buyback Yield / Dilution | 2.12% | 0.26% | 0.59% | 0.44% | - | - | Upgrade
|
| Total Shareholder Return | 3.27% | 1.58% | 1.56% | 0.44% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.